17α-Alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity

被引:18
作者
Boivin, RP [1 ]
Labrie, F [1 ]
Poirier, D [1 ]
机构
[1] Univ Laval, Ctr Hosp Univ Quebec, Med Res Ctr, Med Chem Div,Lab Mol Endocrinol, Quebec City, PQ G1V 4G2, Canada
基金
英国医学研究理事会;
关键词
steroid sulfatase; inhibitor; enzyme; steroid; estradiol; alkylamide; cancel;
D O I
10.1016/S0039-128X(99)00060-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To develop inhibitors of steroid sulfatase without residual estrogenic activity, we have designed a series of estradiol (E-2) derivatives bearing an alkan (or alkyn) amide side chain at position 17 alpha. A hydrophobic alkyl group was selected from our previous study where 17 alpha-octyl-E-2 was found to inhibit strongly the steroid-sulfatase activity. Furthermore, it is known that an alkylamide side chain blocks the estrogen-receptor activation. Starting from ethynylestradiol, the chemical synthesis of target compounds was short and efficient with overall yields of 22-42% (3 or 4 steps). Among these compounds, N-octyl,N-methyl-3-(3',17' beta-dihydroxy-1',3',5'(10')-estratrien-17' alpha-yl)-propanamide (15) was the most potent inhibitor, with an IC50 value of 0.08 mu M for the transformation of estrone sulfate (E1S) to estrone (E-1) by homogenated JEG-3 cells. N-butyl, N-hexyl, and N,N-dioctyl propanamide derivatives of E-2 (IC50 values of 6.4, 2.8, and >20 mu M, respectively) were less potent inhibitors than N-octyl analog 15. Furthermore, the unsaturated propynamide analog of 15 gave lower inhibition (four times) than the saturated compound. Compound 15 is also about 100-fold more effective in interacting with the enzyme than substrate E1S itself. The ability of target compounds to bind the estrogen receptor, to stimulate the proliferation of estrogen-sensitive ZR-75-1 cells, or to inhibit the E-2-stimulation of ZR-75-1 cells was also evaluated. Although a mixed estrogenic/anti-estrogenic activity was obtained for tested compounds at 1 mu M, no estrogenic activity was observed at 0.03 mu M for 15. In conclusion, a promising inhibitor of steroid-sulfatase activity was obtained by introducing a hydrophobic octyl group in a 17 alpha-propanamide side chain of E-2, but further structure-activity relationships (SAR) studies are necessary to minimize the residual estrogenic activity. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:825 / 833
页数:9
相关论文
共 40 条
[11]  
GOTTARDIS MM, 1988, CANCER RES, V48, P812
[12]  
Howell A, 1997, Oncology (Williston Park), V11, P59
[13]  
Jordan V C, 1997, Oncology (Williston Park), V11, P7
[14]  
LABRIE C, 1992, CANCER RES, V52, P610
[15]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NEW HALO-STEROIDAL ANTIESTROGENS [J].
LEVESQUE, C ;
MERAND, Y ;
DUFOUR, JM ;
LABRIE, C ;
LABRIE, F .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (05) :1624-1630
[16]   Development of potent non-estrogenic estrone sulfatase inhibitors [J].
Li, PK ;
Chu, GH ;
Guo, JP ;
Peters, A ;
Selcer, KW .
STEROIDS, 1998, 63 (7-8) :425-432
[17]  
Lombardi P, 1995, CURR PHARM DESIGN, V1, P23, DOI DOI 10.1016/S0925-4439(02)00096-0
[18]  
Luo SQ, 1997, INT J CANCER, V73, P735, DOI 10.1002/(SICI)1097-0215(19971127)73:5<735::AID-IJC21>3.3.CO
[19]  
2-C
[20]  
MacGregor JI, 1998, PHARMACOL REV, V50, P151